SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-093348
Filing Date
2024-08-08
Accepted
2024-08-08 08:01:08
Documents
13
Period of Report
2024-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pepg-20240808.htm   iXBRL 8-K 38501
2 EX-99.1 pepg-ex99_1.htm EX-99.1 103938
3 GRAPHIC img148377401_0.jpg GRAPHIC 5544
  Complete submission text file 0000950170-24-093348.txt   277352

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT pepg-20240808.xsd EX-101.SCH 25792
15 EXTRACTED XBRL INSTANCE DOCUMENT pepg-20240808_htm.xml XML 4875
Mailing Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210
Business Address 1 MARINA PARK DRIVE, SUITE 900 BOSTON MA 02210 703-456-8000
PepGen Inc. (Filer) CIK: 0001835597 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41374 | Film No.: 241186139
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)